Leveraging Quantitative Tools to Integrate Preclinical and Clinical Data to Advance MASH Drug Development
Time: 11:15 am
day: Conference Day 2 Track 2 AM
Details:
- Integrating preclinical and clinical data via mathematical modeling predicts pharmcoldynamic effects on MASH biomarkers
- Mathematical models also characterize the relationship between MASH biomarkers and histological endpoints
- AI/ML techniques aiding participant selection and test model predictions to reduce screen failures
